Therapeutic effect of bromvinyldeoxyuridine and several nucleotides during experimental herpetic infection.
D000818:Animals; D000998:Antiviral Agents; D001085:Arabinofuranosylcytosine Triphosphate / Q000627:therapeutic use; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003563:Cyclic CMP / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D006168:Guinea Pigs; D006566:Herpesviridae Infections / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats
D000998:Antiviral Agents; D003561:Cytarabine; D001085:Arabinofuranosylcytosine Triphosphate; C020235:brivudine; D003563:Cyclic CMP; D001973:Bromodeoxyuridine